Buprenorphine implants helped approximately 40% of patients addicted to opioids markedly reduce their drug use for 6 months in a phase III study of this new method of delivery, according to a report in the Oct. 13 issue of JAMA.
MILAN (EGMN) The novel androgen-blocking agent abiraterone acetate significantly improved overall survival in men with metastatic castration-resistant prostate cancer, the eagerly awaited results of the phase III COU-AA-301 trial have shown.
A lifestyle intervention combining diet and physical activity resulted in significant weight loss and improved cardiovascular risk factors after 12 months in a study of 101 severely obese adults. The results were published online Oct. 9 in JAMA.
WASHINGTON (EGMN) Of 400 United States physicians surveyed online, 95% said they have received flu vaccinations for the 2010-2011 flu season or plan to do so, according to data collected by the National Foundation for Infectious Diseases.
Adding a proton pump inhibitor to dual antiplatelet therapy significantly reduced the risk of gastrointestinal bleeding without raising the risk of cardiovascular events, according to a report published online Oct. 6 in the New England Journal of Medicine.
The headline for the story New APA Recommendations Urge Screening for Anemia at 12 Months (published October 5, 2010) contained an incorrect abbreviation for the American Academy of Pediatrics (AAP).
NATIONAL HARBOR, Md. (EGMN) Age 50 years or older, initial clinical tumor size greater than 5 cm, and pathologic tumor response to neoadjuvant chemotherapy were significant independent predictors of locoregional failure in women who underwent neoadjuvant chemotherapy in two large breast cancer trials.
The cost of colorectal cancer screening could be cut substantially without impairing its effectiveness by adopting a resect and discard approach for the smallest polyps, Dr. Cesare Hassan and his colleagues said in an article appearing in the October issue of Clinical Gastroenterology and Hepatology (doi: 10.1016/j.cgh.2010.05.018).
Men with type 2 diabetes have a moderately higher risk of developing colorectal cancer than do men who are not diabetic, Peter T. Campbell, Ph.D., and his colleagues said in the October issue of Gastroenterology (doi: 10.1053/j.gastro.2010.06.072).
